171 related articles for article (PubMed ID: 9491949)
1. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.
Philbin EF
Clin Cardiol; 1998 Feb; 21(2):103-8. PubMed ID: 9491949
[TBL] [Abstract][Full Text] [Related]
2. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.
Philbin EF; Rocco TA; Lindenmuth NW; Ulrich K; Jenkins PL
Am J Med; 2000 Dec; 109(8):605-13. PubMed ID: 11099679
[TBL] [Abstract][Full Text] [Related]
3. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
[TBL] [Abstract][Full Text] [Related]
4. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.
Philbin EF; Andreaou C; Rocco TA; Lynch LJ; Baker SL
Am J Cardiol; 1996 Apr; 77(10):832-8. PubMed ID: 8623735
[TBL] [Abstract][Full Text] [Related]
5. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function.
Philbin EF; Rocco TA
Am Heart J; 1997 Aug; 134(2 Pt 1):188-95. PubMed ID: 9313596
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction.
Philbin EF; Santella RN; Rocco TA
J Am Geriatr Soc; 1999 Mar; 47(3):302-8. PubMed ID: 10078892
[TBL] [Abstract][Full Text] [Related]
7. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
[TBL] [Abstract][Full Text] [Related]
8. Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study.
Echemann M; Zannad F; Briançon S; Juillière Y; Mertès PM; Virion JM; Villemot JP
Am Heart J; 2000 Apr; 139(4):624-31. PubMed ID: 10740143
[TBL] [Abstract][Full Text] [Related]
9. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
Johnson D; Jin Y; Quan H; Cujec B
J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
[TBL] [Abstract][Full Text] [Related]
10. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
[TBL] [Abstract][Full Text] [Related]
11. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995.
Smith NL; Psaty BM; Pitt B; Garg R; Gottdiener JS; Heckbert SR
Arch Intern Med; 1998 May; 158(10):1074-80. PubMed ID: 9605778
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
13. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals.
Dauterman KW; Go AS; Rowell R; Gebretsadik T; Gettner S; Massie BM
J Card Fail; 2001 Sep; 7(3):221-8. PubMed ID: 11561221
[TBL] [Abstract][Full Text] [Related]
14. Underutilisation of ACE inhibitors in patients with congestive heart failure.
Bungard TJ; McAlister FA; Johnson JA; Tsuyuki RT
Drugs; 2001; 61(14):2021-33. PubMed ID: 11735631
[TBL] [Abstract][Full Text] [Related]
15. Community pharmacist outreach program directed at physicians treating congestive heart failure.
Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study.
Grigorian Shamagian L; Roman AV; Ramos PM; Veloso PR; Bandin Dieguez MA; Gonzalez-Juanatey JR
J Card Fail; 2006 Mar; 12(2):128-33. PubMed ID: 16520261
[TBL] [Abstract][Full Text] [Related]
17. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
Giles TD; Fisher MB; Rush JE
Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.
Mujib M; Patel K; Fonarow GC; Kitzman DW; Zhang Y; Aban IB; Ekundayo OJ; Love TE; Kilgore ML; Allman RM; Gheorghiade M; Ahmed A
Am J Med; 2013 May; 126(5):401-10. PubMed ID: 23510948
[TBL] [Abstract][Full Text] [Related]
19. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
20. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]